e-learning
resources
Barcelona 2010
Monday, 20.09.2010
COPD and asthma: models and human studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results
A. Proklou, E. Neofytou, M. Psarrou, S. Schiza, N. Siafakas, E. Tzortzaki (Heraklion, Greece)
Source:
Annual Congress 2010 - COPD and asthma: models and human studies
Session:
COPD and asthma: models and human studies
Session type:
E-Communication Session
Number:
1985
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Proklou, E. Neofytou, M. Psarrou, S. Schiza, N. Siafakas, E. Tzortzaki (Heraklion, Greece). LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results. Eur Respir J 2010; 36: Suppl. 54, 1985
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Perforin expression in lung tissue of COPD patients: preliminary results
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007
Bacterial load in induced sputum from acute asthma (preliminary results)
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018
LSC 2011 Abstract: Association of IL-9 and IL-4R genes and their phenotypes among Sudanese with asthma
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
Serum and sputum perforin and granzymes A and B expression in persistent asthma
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
LSC 2010 Abstract: Role of B-lymphocytes in a mouse model of chemical-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Asthma and chronic rhinosinusitis: comparative evaluation of IgE plasma level, CD23+ and blood eosinophils
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
Expression of miR-185 targets DNA methyltransferase 1 and Cyclin D2 in IPF and lung cancer in BALF cells: Preliminary results
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Late-breaking abstract: Repeated analysis of alpha-1-antitrypsin concentrations in sputum, lavage and serum of smokers with and without COPD
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene)
Source: Eur Respir J 2001; 18: Suppl. 33, 371s
Year: 2001
Cytokine receptors expression in induced sputum in asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001
Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004
The effect of montelukast on eosinophil apoptosis: Induced sputum findings of patients with mild persistant asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 101s
Year: 2003
Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
LSC 2011 Abstract: Changes in the proteome upon dermal sensitization in a mouse model of chemical-induced asthma
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept